Mechanisms of defective hydroosmotic response in chronic renal failure

Journal of Nephrology

Volumn 10, Issue 5, 1997, Pages 232-237

  Osorio, Fredrick V ^a   Teitelbaum, Isaac ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Chronic renal failure; Urinary concentrating capacity; Vasopressin

Indexed keywords

CHRONIC KIDNEY FAILURE; HUMAN; KIDNEY CONCENTRATING CAPACITY; KIDNEY MEDULLA; KIDNEY TUBULE; NOCTURIA; NONHUMAN; OSMOREGULATION; REVIEW; WATER PERMEABILITY;

ANIMALS; ARGININE VASOPRESSIN; HUMANS; KIDNEY CONCENTRATING ABILITY; KIDNEY FAILURE, CHRONIC; KIDNEY MEDULLA;

EID: 0030662464     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Dorhout Mees EJ. Role of osmotic diuresis in impairment of concentrating ability in renal disease. Br Med J 1959; 1: 1156-8.
2. Tannen RL, Regal EM, Dunn MJ, Schrier RW. Vasopressin-resistant hyposthenuria in advanced chronic renal disease. N Engl J Med 1969; 280: 1135-41.
3. de Wardener HE, del Greco F. Influence of solute excretion rate on production of hypotonic urine in man. Clin Sci 1955; 14: 715.
4. Bricker NS, Dewey RR, Lubowitz H, Stokes J, Kirkensgaard T. Observations on the concentrating and diluting mechanisms of the diseased kidney. J Clin Invest 1959; 38: 516-23.
5. Kleeman CR, Adams DA, Maxwell MH. An evaluation of maximal water diuresis in chronic renal disease. I. Normal solute intake. J Lab Clin Med 1961; 58: 169-84.
6. Rocha AS, Kokko JP. Sodium chloride and water transport in the medullary thick ascending limb of Helne. Evidence for active chloride transport. J Clin Invest 1973; 52: 612-23.
7. Gilbert RM, Weber H, Turchin L, Fine LG, Bourgoignie JJ, Bricker NS. A study of the intrarenal recycling of urea in the rat with chronic experimental pyelonephritis. J Clin Invest 1976; 58: 1348-57.
8. Bank N, Aynedjian HS. Individual nephron function in experimental pyelonephritis. II. Distal tubular sodium and water reabsorption and the concentrating defect. J Lab Clin Med 1966; 68: 728-39.
9. Kokko JP, Rector FC. Countercurrent multiplication system without active transport in inner medulla. Kidney Int 1972; 2: 214-21.
10. Finkelstein FO, Hayslett JP. Role of medullary structures in the functional adaptation of renal insufficiency. Kidney Int 1974; 6: 419-25.
11. Martinez-Maldonado M, Yium JJ, Eknoyan G, et al. Adult polycystic disease: studies of the defect in urine concentration. Kidney Int 1972; 2: 107-15.
12. Gabow PA, Kaehny WD, Johnson AM, et al. The clinical utility of renal concentrating capacity in polycystic kidney disease. Kidney Int 1989; 35: 675-59.
13. Hatch PE, Culbertson JW, Diggs LW. Nature of the renal concentrating defect in sickle cell disease. J Clin Invest 1967; 46: 336-42.
14. Nanra RS, Stuart-Taylor J, de Leon AH, et al. Analgesic nephropathy: etiology, clinical syndrome and clinicopathologic correlations in Australia. Kidney Int 1978; 13: 79-94.
15. Jawandi MH, Ho LS, Dipet'e D, Ross DL. Regulation of plasma arginine vasopressin in patients with chronic renal failure maintained on hemodialysis. Am J Nephrol 1986; 6: 175-81.
16. Amico JA, Silver MR, Finn FM, Robinson AG. High performance liquid chromatographic characterization of neurophysisns in chronic renal failure. J Lab Clin Med 1987; 110: 439-47.
17. Argent NB, Burrell LM, Goodship THJ, Wilkinson R, Baylis PH. Osmoregulation of thirst and vasopressin release in severe chronic renal failure. Kidney Int 1991; 39: 295-300.
18. Benmansom M, Ramfray M, Paillard M. Metabolic clearance rate of immunoreactive vasopressin in man. Eur J Clin Invest 1982; 12: 475-80.
19. Fine LG, Schlondorff D, Trizna W, Gilbert RM, Bricker NS. Functional profile of the isolated uremic nephron. J Clin Invest 1978; 60: 1519-27.
20. Dousa TP. Cellular action of antidiuretic hormone. Miner Electrolyte Metab 1981; 5: 144-51.
21. Abramov M, Beauwens R, Cogan E. Cellular events in ADH action. Kidney Int 1987; 32 (Suppl 21): S-56.
22. Muller J, Kachadorian WA, DiScala VA. Evidence that ADH-stimulated intramembranous particle aggregates are transferred from cytoplasmic to luminal membranes in toad bladder epithelial cells. J Cell Biol 1980; 85: 83-7.
23. Strange K, Spring KR. Absence of significant cellular dilution during ADH-stimulated water reabsorption. Science 1987; 235: 1068-72.
24. 2 receptor mRNA. J Clin Invest 1995; 96: 378-85.
25. Dunn MJ. Renal prostaglandins. In: Dunn MJ, ed. Renal endocrinology. Baltimore, MD: Williams and Wilkins 1983; 1-74.
26. Beck T, Dunn M. The relationship of antidiuretic hormone and renal prostaglandins. Miner Electrolyte Metab 1981; 6: 46-53.
27. 2, forskolin, and cholera toxin interactions in rabbit cortical collecting tubule. Am J Physiol 1986; 250 (1 pt 2): F127-35.
28. Sato M, Dunn MJ. Interactions of vasopressin, prostaglandins, and cAMP in rat renal papillary collecting tubule cells in culture. Am J Physiol 1984; 247: F423-33.
29. Caramelo C, Tsai P, Okada K, Schrier RW. Protein kinase C activity in compensatory kidney growth. Biochem Biophys Res Commun 1988; 152: 315-21.
30. i-dependent mechanism. Am J Physiol 1993; 264: F216-20.
31. Ando Y, Jacobson HR, Breyer MD. Both branches of phosphatidylinositol breakdown cascade inhibit vasopressin action in cortical collecting tubule. In: Cowley Jr. AW, Liard J-F, Ausiello DA, eds. Vasopressin. Cellular and integrative functions. New York: Raven Press 1988; 127-36.
32. Margolis B, Angel J, Kremer S, Skorecki K. Vasopressin action in the kidney-Overview and glomerular actions. In: Cowley Jr. AW, Liard J-F, Ausiello DA, eds. Vasopressin. Cellular and integrative functions. New York: Raven Press 1988; 97-106.
33. Teitelbaum I, Berl T. Effects of calcium on vasopressin-mediated cAMP formation in cultured rat inner medullary collecting tubule cells. Kidney Int 1989; 35: 647-53.
34. Teitelbaum I, Berl T. Increased cytosolic calcium inhibits AVP-stimulated adenylyl cyclase activity in rat IMCT cells by activation of PKC. Am J Physiol 1994; 266: F486-90.
35. Teitelbaum I, Strasheim A, McGuinness S. Decreased aquaporin (AQP)-2 content in chronic renal failure. J Am Soc Nephrol 1996; 7: 1273 (abst).